Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CB.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BR.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BR.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CL.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.10.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.10.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBTNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBTNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EJ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.1.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.1.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.123.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.123.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.9.2.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.9.2.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EW.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.23.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.23.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.21.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.21.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.16.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.49NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used